W czasie kryzysu i niedoborów w systemach opieki zdrowotnej, władze szpitali, pod nadzorem władz publicznych i organizacji zawodowych muszą podejmować trudne decyzje aby jak najlepiej zapewnić optymalne i bezpieczne warunki pracy.
Piśmiennictwo:
1. Gorbalenya A.E., Baker S.C., Baric R.S. i wsp.: The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020; 5: 536–544.2. https://covid19.who.int/ dostępne 30.06.2020.
3. Cao Y., Li L., Feng Z. i wsp.: Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 2020; 24; 6: 11. doi: 10.1038/s41421-020-0147-1.
4. Thomson G.: COVID-19: social distancing, ACE 2 receptors, protease inhibitors and beyond? Int. J. Clin. Pract. 2020; 18:e13503. doi: 10.1111/ijcp.13503.
5. Guan W., Ni Z., Hu Y. i wsp.: Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020; 382: 1708 –1720.
6. Wu Z., McGoogan J.M.: Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239 –1242.
7. Tahamtan A., Ardebili A.: Real-time RT-PCR in COVID-19 detection: issues affecting the results. Exp. Rev. Mol. Diag. 2020; 20: 5: 453 –454.
8. Du Z., Zhu F., Guo F. i wsp.: Detection of Antibodies Against SARS-CoV-2 in Patients With COVID-19. J. ed.. Virol. 2020; 3;10. doi: 10.1002/jmv.25820.
9. Lei Y., Zhang H.W., Yu J., Patlas M.N.:COVID-19 Infection: Early Lessons. Can. Assoc. Radiol. J. 2020; 12:846537120914428. doi: 10.1177/0846537120914428.
10. Ai T., Yang Z., Hou H. i wsp.: Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology 2020; doi: /10.1148/radiol.2020200642.
11. Kupferschmidt K., Cohen J.: Race to Find COVID-19 Treatments Accelerates Science. 2020; 27; 367(6485): 1412 –1413.
12. Mehta P., McAuley D.F., Brown M. i wsp.: COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression. Lancet. 2020; 395(10229): 1033 –1034.
13. El-Aziz T.M.A., Stockand J.D.: Recent Progress and Challenges in Drug Development Against COVID-19 Coronavirus (SARS-CoV-2) – An Update on the Status. Infect. Genet. Evol. 2020; 83: 104327. doi: 10.1016/j.meegid.2020.104327.
14. Jones D.S.: History in a Crisis - Lessons for Covid-19. N. Engl. J. Med. 2020; doi: 10.1056/NEJMp2004361.
15. McCloskey B., Heymann D.L.: SARS to novel coronavirus: old lessons and new lessons. Epidemiol. Infect. 2020;148:e22. doi:10.1017/S0950268820000254.
16. Signorelli C., Fara G.M.: COVID-19: Hygiene and Public Health to the Front. Acta Biomed. 2020; 7;91(3-S): 7–8.
17. https://www.who.int/news-room/q-a-detail/q-a-considerations-for-the-cleaning-and-disinfection-of-environmental-surfaces-in-the-context-of-covid-19-in-non-health-care-settings dostępne 30.06.2020.
18. Chu D., Akl E., El-Harakeh A., Bognanni A. i wsp.: Physical Distancing, Face Masks, and Eye Protection to Prevent Person-Person COVID-19 Transmission: A Systematic Review and Meta-Analysis. 2020; doi.org/10.2139/ssrn.3578764.
